Related Experiment Video
Updated: Jul 10, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
A-GSTCN: An Augmented Graph Structural-Temporal Convolution Network for Medication Recommendation Based on Electronic
Weiqi Yue1, Maiqiu Wang2, Lei Zhang1,2
1School of Electronic and Information Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.
Abstract:
Medication recommendation based on electronic health records (EHRs) is a significant research direction in the biomedical field, which aims to provide a reasonable prescription for patients according to their historical and current health conditions. However, the existing recommended methods have many limitations in dealing with the structural and temporal characteristics of EHRs. These methods either only consider the current state while ignoring the historical situation, or fail to adequately assess the structural correlations among various medical events. These factors result in poor recommendation quality. To solve this problem, we propose an augmented graph structural-temporal convolutional network (A-GSTCN). Firstly, an augmented graph attention network is used to model the structural features among medical events of patients' EHRs. Next, the dilated convolution combined with residual connection is applied in the proposed model, which can improve the temporal prediction capability and further reduce the complexity. Moreover, the cache memory module further enhances the model's learning of the history of EHRs. Finally, the A-GSTCN model is compared with the baselines through experiments, and the efficiency of the A-GSTCN model is verified by Jaccard, F1 and PRAUC. Not only that, the proposed model also reduces the training parameters by an order of magnitude.
More Related Videos
Related Concept Videos
Time Course of Drug Effect
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

